Baraldi PG - Search Results

1

The A3 adenosine receptor: history and perspectives.

Borea PA, Varani K, Vincenzi F, Baraldi PG, Tabrizi MA, Merighi S, Gessi S. Borea PA, et al. Among authors: baraldi pg. Pharmacol Rev. 2015;67(1):74-102. doi: 10.1124/pr.113.008540. Pharmacol Rev. 2015. PMID: 25387804 Review.

2

Binding thermodynamics at the human A(3) adenosine receptor.

Merighi S, Varani K, Gessi S, Klotz KN, Leung E, Baraldi PG, Borea PA. Merighi S, et al. Among authors: baraldi pg. Biochem Pharmacol. 2002 Jan 15;63(2):157-61. doi: 10.1016/s0006-2952(01)00825-5. Biochem Pharmacol. 2002. PMID: 11841789

3

Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.

Baraldi PG, Fruttarolo F, Tabrizi MA, Preti D, Romagnoli R, El-Kashef H, Moorman A, Varani K, Gessi S, Merighi S, Borea PA. Baraldi PG, et al. J Med Chem. 2003 Mar 27;46(7):1229-41. doi: 10.1021/jm021023m. J Med Chem. 2003. PMID: 12646033

4

Recent developments in the field of A2A and A3 adenosine receptor antagonists.

Baraldi PG, Tabrizi MA, Bovero A, Avitabile B, Preti D, Fruttarolo F, Romagnoli R, Varani K, Borea PA. Baraldi PG, et al. Eur J Med Chem. 2003 Apr;38(4):367-82. doi: 10.1016/s0223-5234(03)00042-4. Eur J Med Chem. 2003. PMID: 12750024

5

New strategies for the synthesis of A3 adenosine receptor antagonists.

Baraldi PG, Bovero A, Fruttarolo F, Romagnoli R, Tabrizi MA, Preti D, Varani K, Borea PA, Moorman AR. Baraldi PG, et al. Bioorg Med Chem. 2003 Sep 15;11(19):4161-9. doi: 10.1016/s0968-0896(03)00484-x. Bioorg Med Chem. 2003. PMID: 12951147

6

A glance at adenosine receptors: novel target for antitumor therapy.

Merighi S, Mirandola P, Varani K, Gessi S, Leung E, Baraldi PG, Tabrizi MA, Borea PA. Merighi S, et al. Among authors: baraldi pg. Pharmacol Ther. 2003 Oct;100(1):31-48. doi: 10.1016/s0163-7258(03)00084-6. Pharmacol Ther. 2003. PMID: 14550503 Review.

7

Synthesis and biological evaluation of novel N6-[4-(substituted)sulfonamidophenylcarbamoyl]adenosine-5'-uronamides as A3 adenosine receptor agonists.

Baraldi PG, Fruttarolo F, Tabrizi MA, Romagnoli R, Preti D, Bovero A, Pineda de Las Infantas MJ, Moorman A, Varani K, Borea PA. Baraldi PG, et al. J Med Chem. 2004 Oct 21;47(22):5535-40. doi: 10.1021/jm0408161. J Med Chem. 2004. PMID: 15481989

8

Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine ligands, new tools to characterize A3 adenosine receptors in human tumor cell lines.

Baraldi PG, Tabrizi MA, Romagnoli R, Fruttarolo F, Merighi S, Varani K, Gessi S, Borea PA. Baraldi PG, et al. Curr Med Chem. 2005;12(11):1319-29. doi: 10.2174/0929867054020963. Curr Med Chem. 2005. PMID: 15974999 Review.

9

New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A3 adenosine receptor antagonists.

Baraldi PG, Preti D, Tabrizi MA, Fruttarolo F, Romagnoli R, Zaid NA, Moorman AR, Merighi S, Varani K, Borea PA. Baraldi PG, et al. J Med Chem. 2005 Jul 14;48(14):4697-701. doi: 10.1021/jm058008c. J Med Chem. 2005. PMID: 16000006

10

A3 adenosine receptors modulate hypoxia-inducible factor-1alpha expression in human A375 melanoma cells.

Merighi S, Benini A, Mirandola P, Gessi S, Varani K, Leung E, MacLennan S, Baraldi PG, Borea PA. Merighi S, et al. Among authors: baraldi pg. Neoplasia. 2005 Oct;7(10):894-903. doi: 10.1593/neo.05334. Neoplasia. 2005. PMID: 16242072 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

247 results

Search Page